UVISA Fii
Treating vaginal infections using light instead of antibiotics.
Developing a non-pharmacological treatment for vaginal infections
Leading product development for UVISA's first-of-its-kind home-treatment device that uses light therapy to treat bacterial vaginosis (BV) and candidiasis. Coordinating cross-functional teams spanning embedded firmware, mobile app development, and mechanical engineering to deliver a drug-free alternative that empowers women to manage intimate health at home.
Form studies evaluating ergonomics and aesthetics
Rendering of the chosen concept
3D printed prototype validating machanics and electronics
Balancing thermal constraints with therapeutic efficacy
Navigating Class IIa medical device regulations (ISO 13485, IEC 60601, ISO 62304) while driving design innovation. The core engineering challenge: optimizing light output for therapeutic effectiveness while managing heat dissipation within intimate body contact limits. Employed computational design generation and parametric evaluation to iterate rapidly on thermal-optical trade-offs, improving product economics through material and geometry optimization.
DFM evaluation with oversea suppliers
Validating temperature at dosage radiation
From concept to clinical validation
Developed complete product architecture from concept through DFM-ready design, reducing BOM cost by 35% through parametric optimization (not shown here). Established comprehensive documentation frameworks meeting EU MDR Class IIa requirements across 50+ technical files. The device has successfully completed clinical trials at Odense University Hospital with 30+ participants, targeting a non-pharmacological solution for the 1 in 3 women affected by BV annually.
Role
Chief Product Officer
Timeline
2024 – Present